Relationship between B-type natriuretic peptide serum level, echocardiographic TEI index and the degree of diastolic dysfunction in patients with heart failure with preserved systolic function

Archives of Medical Science

Volumn 7, Issue 3, 2011, Pages 449-456

  Karasek, Danuta ^a   Sinkiewicz, Władysław ^a   Błazejewski, Jan ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

B type natriuretic peptide; Heart failure with preserved systolic function; TEI index

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INDEX; HEART MUSCLE RELAXATION; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; TEI INDEX;

EID: 79960466607     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.23411     Document Type: Article

References (30)

1. Grigorian SL, Gonzalez-Juanatey JR, Roman AV, et al. The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge: evolution over a 10-year period. Eur Heart J 2005; 26: 2251-8. (Pubitemid 41541388)
2. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2005; 46: 1116-43.
3. Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005; 330: 625.
4. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 2004; 109: 3176-81.
5. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproductible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995; 2: 357-66. (Pubitemid 26011184)
6. Textbook of AxSYM BNP Abbott System No REF 8G82-20 test. 2005.
7. Feigenbaum H, Armstrong WF, Ryan T. Echokardiografia. Lippincott Williams &Wilkins 2005; 173-84.
8. Rakowski H, Appelton CP, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996; 9: 736.
9. McDonagh TA. Asymptomatic left ventricular dysfunction in the community. Curr Cardiol Rep 2000; 2: 470-4.
10. Nakao S, Goda A, Yuba M, et al. Characterisation of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure. Circulation J 2007; 71: 1412-7. (Pubitemid 47378442)
11. Grewal J, McKelvie R, Lonn E, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008; 10: 252-9. (Pubitemid 351343862)
12. Maisel AS, McCord J, Nowak RMJ, et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. Am Coll Cardiol 2003; 41: 2010-7. (Pubitemid 36677124)
13. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA 2006; 296: 2209-16. (Pubitemid 44708051)
14. Thomas MD, Fox KF, Wood DA, et al. Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function. Heart 2006; 92: 603-8.
15. Wei T, Zeng C, Chen L, et al. Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide. Int J Clin Pract 2005; 59: 891-4.
16. Tschöpe C, Kasner M, Westermann D, et al. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 2005; 26: 2277-84. (Pubitemid 41541392)
17. Martos R, Baugh J, Ledwidge M, et al. Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover. Eur J Heart Fail 2009; 11: 191-7.
18. Troughton RW, Richards AM. B-type natriuretic peptides and echocardiographic measures of cardiac structure and function. J Am Cool Cardiol Img 2009; 2: 216-25.
19. Dahlström U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 2004; 6: 281-7.
20. Lukowicz TV, Fischer M, Hense HW, et al. BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. Eur J Heart Fail 2005; 7: 525-31. (Pubitemid 40732982)
21. Wieczorek SJ, Wu A, Christenson R. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002; 144: 834-9. (Pubitemid 35335175)
22. Caboral M, Mitchell J. B-type natriuretic peptide: a new tool in the armamentarium used to accurately diagnose heart failure. Prog Cardiovasc Nurs 2003; 18: 190-3.
23. Parthenakis FI, Kanakaraki MK, Kanoupakis EM, et al. Value of Doppler index combining systolic and diastolic myocardial performance in predicting cardiopulmonary exercise capacity in patients with congestive heart failure. Chest 2002; 121: 1935-41. (Pubitemid 34634417)
24. Sutton MJ, Wiegers SE. The Tei index - a role in the diagnosis of heart failure? Eur Heart J 2000; 21: 1822-4.
25. Zhang H, Otsuji Y, Matsukida K, et al. Noninvasive differentiation of normal from pseudonormal/restrictive mitral flow using TEI index combining systolic and diastolic function. Circ J 2002; 66: 831-6.
26. Su HM, Lin TH, Voon WC, et al. Differetiation of left ventricular diastolic dysfunction, identification of pseudonormal/restrictive mitral inflow pattern and determination of left ventricular filling pressure by Tei index obtained from tissue Doppler echocardiography. Echocardiography 2006; 23: 287-94.
27. Keser N, Yildiz S, Kurto N, et al. Modiifed TEI index: a promising parameter in essential hypertension? Echocardiography 2005; 22: 296-304.
28. Bruch C, Gradaus R, Gunia S, et al. Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure. J Am Soc Echocardiogr 2003; 16: 1031-6. (Pubitemid 37210929)
29. Tanabe K, Ono M, Asanuma T, et al. Doppler echocardiography - derived index of myocardial performance (TEI index): comparison with brain natriuretic peptide levels in various hart disease. Jpn Circ J 2001; 65: 637-42.
30. Okawa M, Kitaoka H, Matsumura Y, et al. Functional assessment by myocardial performance index (Tei index) correlates with plasma brain natriuretic peptide concentration in patients with hypertrophic cardiomyopathy. Circ J 2005; 69: 951-7. (Pubitemid 41124264)